Gil-Sierra, Manuel David http://orcid.org/0000-0002-7342-9495
del Pilar Briceño-Casado, Maria
Sánchez-Hidalgo, Marina
Article History
Received: 18 August 2021
Accepted: 10 January 2022
First Online: 13 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Gil-Sierra Manuel David: membership of an advisory board (consultation fees), lecture for Janssen Pharmaceutica and Pfizer (reimbursement for attending symposia) of cancer drugs. The rest of the authors have no conflict of interest to declare.